secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001193125-23-144274
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ikena raises ~$40M in equity offering; Q1 cash $137.8M; runway to 2026
----------------------------------------------------------------------

- Underwritten offering of 6.11M shares at $6.55/share for gross proceeds of ~$40M; closing expected May 17, 2023.
- Cash, equivalents and marketable securities $137.8M at March 31, 2023; offering proceeds extend cash runway into 2026.
- Q1 collaboration revenue $5.3M (up from $3.4M YoY); R&D expense $15.6M; G&A $5.3M.
- IK-930 initial monotherapy data expected 4Q 2023; IK-595 IND filing planned 2H 2023; IK-175 Fast Track designation in March.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312523144274/0001193125-23-144274-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312523144274/d504516d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-144274

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer